BVF »

Adagio Therapeutics shares owned by BVF

Quarter-by-quarter ownership of Adagio Therapeutics (IVVD) shares owned by BVF from 13F filings

Historical chart of BVF investment in Adagio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adagio Therapeutics held by BVF consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adagio Therapeutics by BVF

Quarter filed Position value Share count Share price at filing
2025-12-31 $48M 20M 2.47

More positions owned by BVF

Kymera Therapeutics (KYMR)
Revolution Medicines (RVMD)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Structure Therapeutics Sponsored Ads (GPCR)
Olema Pharmaceuticals (OLMA)
Mirum Pharmaceuticals (MIRM)
Gh Research Ordinary Shares (GHRS)
Xencor (XNCR)
Zymeworks Del (ZYME)
Palvella Therapeutics Inc Ne (PVLA)
Kura Oncology (KURA)
Stoke Therapeutics (STOK)
Xoma Royalty Corporation Com New (XOMA)
Abivax Sa Sponsored Ads (ABVX)
Nektar Therapeutics Com New (NKTR)

View all positions for BVF

Top funds holding Adagio Therapeutics

Perceptive Advisors
BVF
Maverick Capital
RA Capital Management
Point72 Asset Management
Driehaus Capital Management
Vanguard Group
M28 Capital Management
Saturn V Capital Management
Soleus Capital Management
Eventide Asset Management
State Street Corporation
Siren
ADAR1 Capital Management
Balyasny Asset Management

View all funds holding Adagio Therapeutics